In Case 2, NUTM1 break-apart and BRD4::NUTM1 fusion signals were observed in 84% and 75% of the tumor cells, respectively, with in-frame breakpoints in BRD4 exon 11 and NUTM1 exon 3 (Figure 3B). The gene discussed is BRD4; the disease is neoplasm.